Gryphon Scientific specializes in biosafety, biosecurity, and all-hazards preparedness and response, leveraging advanced technologies to enhance public health and safety. The company employs artificial intelligence (AI) to improve detection, prevention, and emergency response capabilities related to biological and chemical threats. With a multidisciplinary team of scientists, programmers, and policy professionals, Gryphon focuses on data-driven solutions that inform safe policy and practice around emerging technologies. Their expertise extends to risk assessment and modeling, enabling organizations to navigate the complexities of public health challenges effectively.

In addition to its core competencies in biosecurity, Gryphon is committed to fostering collaboration across sectors to address critical issues in life sciences. The company has a strong track record of supporting government and commercial entities in evaluating and developing technologies that mitigate risks associated with biological emergencies. By integrating their scientific knowledge with advanced data analytics, Gryphon aims to enhance the preparedness and response capabilities of its clients, ultimately contributing to a safer and healthier society.

United States

In April 2024, Deloitte acquired substantially all of the assets of Gryphon Scientific LLC. The team, comprised of life scientists and health researchers who apply rigorous scientific analysis to problems of global health and homeland security, is now part of the Deloitte GPS Federal Health sector. Our projects drive policy changes in security, preparedness, and science policy at the highest levels of US government.

Gryphon Scientific

Company Details